Ophthalmologic manifestations as the initial presentation of chronic myeloid leukemia: A review.

Mohamed A Yassin, Fateen Ata, Shehab F Mohamed, Ameen Alkhateeb, Usman Naeem, Ahmed I Al-Qatami, Abdulqadir J Nashwan, Liam J Fernyhough

Journal: Survey of ophthalmology 2022;67(2):530-543

PMID: 34252423

Abstract

The presentation of chronic myeloid leukemia (CML) can be variable and related to the phase of the disease. It can manifest a wide range of symptoms and signs; ocular involvement is reported in patients with leukemia at the time of diagnosis. We describe ophthalmic manifestations as an initial presentation in patients with CML. We identified 38 publications between 1971 and 2020 describing ocular manifestations in CML. Ophthalmic problems occur either from direct or indirect infiltration of neoplastic cells or from secondary causes. Although nearly all ocular structures may be affected, leukemic retinopathy is the most frequent clinical manifestation. Others include iris infiltration, anterior uveitis, hypopyon, exudative/serous retinal detachment, and optic nerve infiltration.

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Address: Hematology Section, Medical Oncology Department, National Center for Cancer Care and Research, Hamad Medical Corporation (HMC), Doha, Qatar.; Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.; Ophthalmology Department, Hamad Medical Corporation (HMC), Doha, Qatar.; Hematology Section, Medical Oncology Department, National Center for Cancer Care and Research, Hamad Medical Corporation (HMC), Doha, Qatar. Electronic address: [email protected].; Weill Cornell Medicine in Qatar, Doha, Qatar.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.